- within Food, Drugs, Healthcare and Life Sciences topic(s)
- within Antitrust/Competition Law and Law Practice Management topic(s)
At Jones Walker, our Healthcare Industry Team is excited about the endless opportunities the digital healthcare landscape can provide for physical and mental health and well-being in Louisiana.
Five years after COVID-19 accelerated telemedicine adoption, the domestic digital health landscape remains unsettled. Pandemic-era waivers expanded access to care, particularly for rural and underserved populations, but many expired September 30, creating uncertainty for providers and investors. Federal funding cuts and shifting compliance priorities further complicate long-term planning.
Despite domestic challenges, digital health aligns with global trends. The World Health Organization's Global Initiative on Digital Health promotes country-led transformation, with most surveyed nations advancing in digital maturity. US policymakers continue balancing innovation with regulation amid evolving enforcement priorities.
Licensure and interstate practice
Telemedicine growth exposed outdated state licensure laws. The
Interstate Medical Licensure Compact streamlines multistate
practice for physicians, but costs remain high —
$300–$700 per license. A pending lawsuit challenges
restrictive state laws, potentially reshaping licensure nationwide.
Providers must monitor compliance closely as rules evolve.
Medicare and telehealth reimbursement
Post-federal Public Health Emergency, the US Centers for Medicare
& Medicaid Services extended several telehealth flexibilities.
Behavioral health telehealth services and audio-only options are
permanent, while most nonbehavioral provisions expire in 2025. The
Drug Enforcement Agency extended remote prescribing flexibilities
through December 31, 2025. However, heightened scrutiny on fraud
and cost containment creates reimbursement uncertainty, especially
for smaller practices.
Investment and innovation
Economic volatility and federal cost-cutting have slowed growth,
yet venture capital remains strong for clinically validated
solutions. AI-powered platforms for diagnostics, workflow
optimization, and revenue cycle management attract funding. Still,
reduced federal research support and lack of integrated trial
platforms pose challenges. Concerns about limiting
demographic-based research could hinder efforts to address health
disparities.
AI's expanding role
AI is transforming specialties like radiology and dermatology,
prompting shifts in workforce dynamics. While AI augments clinical
judgment, its risks include bias, liability, and Health Insurance
Portability and Accountability Act (HIPAA) compliance. The Food and
Drug Administration's (FDA) 2025 draft guidance mandates
rigorous validation for AI-enabled devices. Medical schools now
incorporate AI literacy, and professional societies develop usage
guidelines. Developers must design tools that complement —
not replace — physician decision-making.
Cybersecurity and oversight
Budget cuts at the Department of Health and Human Services Office
for Civil Rights may weaken HIPAA enforcement as healthcare data
breaches surge. New HIPAA cybersecurity rules are expected, but
implementation remains uncertain. AI integration amplifies data
security risks, requiring robust technical and human-factor
safeguards.
Corporate practice and market
consolidation
State laws restricting corporate practice of medicine complicate
private equity investment in telehealth. Hospital mergers aimed at
scalability raise antitrust and access concerns. Until states
modernize regulations, providers must maintain rigorous compliance
across jurisdictions.
Reproductive telehealth challenges
Post-Dobbs, reproductive telehealth faces fragmented state
laws and privacy concerns. Medication abortion via telehealth
remains contentious, with ongoing litigation challenging FDA rules.
Providers often limit geographic reach to avoid legal exposure,
reducing access in restrictive states.
In conclusion, digital health is now integral to American healthcare, offering improved access and efficiency. Yet regulatory complexity, funding uncertainty, and ethical challenges persist. Success depends on proactive compliance, strong cybersecurity, and balanced regulation that fosters innovation while protecting patients. Organizations that navigate these dynamics while delivering measurable clinical value will shape the future of healthcare.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.